Standout Papers
Citation Impact
Citing Papers
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
True
2000
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
Human Papillomavirus Infections in Nonmelanoma Skin Cancers From Renal Transplant Recipients and Nonimmunosuppressed Patients
1996
Efficient production of chimeric Human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants
2011
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine
2010
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
HPV testing in cervical screening
2001
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
2000
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
2007
The epidemiology of human papillomavirus infections
2005
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Global Cancer Statistics, 2002
2005 Standout
Asbestos Exposure and Gastrointestinal Malignancy Review and Meta‐Analysis
1988
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
The role of TP53 in Cervical carcinogenesis
2003
Identifying Women With Cervical Neoplasia
1999
Human papillomavirus variants and squamous neoplasia of the cervix
2001
HPV DNA Testing in Cervical Cancer Screening
2000
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
The viral origin of cervical cancer in Rabat, Morocco
1998
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
The contribution of outdoor air pollution sources to premature mortality on a global scale
2015 StandoutNature
Recent advances in strategies for immunotherapy of human papillomavirus‐induced lesions
2007
Novel HPV types present in oral papillomatous lesions from patients with HIV infection
1996
Photodynamic therapy of cervical intraepithelial neoplasia with hexaminolevulinate
2008
Atomic model of the papillomavirus capsid
2002
Risk Factors for Cervical Cancer in Thailand: a Case-Control Study
1998
Chimeric Virus-like Particles of the Human Papillomavirus Type 16 (HPV 16) as a Prophylactic and Therapeutic Vaccine
1999
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
2000 Standout
The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2
1997
Lung Cancer, Cardiopulmonary Mortality, and Long-term Exposure to Fine Particulate Air Pollution
2002 Standout
Evaluation of Genital Sites and Sampling Techniques for Detection of Human Papillomavirus DNA in Men
2004
Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study
2005
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
1998 StandoutNature
Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity
1998
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 Standout
Development and Assessment of a General Theory of Cervical Carcinogenesis Utilizing a Severe Combined Immunodeficiency Murine–Human Xenograft Model
2000
Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
2002
Against which human papillomavirus types shall we vaccinate and screen? the international perspective
2004
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Global cancer statistics
2011 Standout
Prevalence and Risk Factors for Human Papillomavirus Infection of the Anal Canal in Human Immunodeficiency Virus (HIV)‐Positive and HIV‐Negative Homosexual Men
1998
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Markers of Dysglycaemia and Risk of Coronary Heart Disease in People without Diabetes: Reykjavik Prospective Study and Systematic Review
2010
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Structure of Small Virus-like Particles Assembled from the L1 Protein of Human Papillomavirus 16
2000
Transcriptional activation of H- and N-ras oncogenes in human cervical cancer
2004
Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies
2010
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Papillomavirus Is Resistant to Desiccation
1997
Homocysteine and Risk of Ischemic Heart Disease and Stroke
2002 Standout
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
2000
A longitudinal study of HPV detection and cervical pathology in HIV infected women
2000
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
The polycomb group protein EZH2 is involved in progression of prostate cancer
2002 StandoutNature
Human Papillomavirus Type 16 Variants and Risk of Cervical Cancer
2001
A review of mammalian carcinogenicity study design and potential effects of alternate test procedures on the safety evaluation of food ingredients
2010
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Inhibition of NF-κB Activation by Arsenite through Reaction with a Critical Cysteine in the Activation Loop of IκB Kinase
2000 StandoutNobel
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
2002
Antibodies against Human Herpesvirus 8 in Black South African Patients with Cancer
1999
Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation
1997
An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer
1995
Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1
2001
Sexual Behavior and Partner Characteristics Are the Predominant Risk Factors for Genital Human Papillomavirus Infection in Young Women
1996
Screening for Genital Human Papillomavirus
1999
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
1998 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Roots and perspectives of contemporary papillomavirus research
1996 StandoutNobel
HPV Prevalence among Mexican Women with Neoplastic and Normal Cervixes
1998
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
2000 Standout
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
1998
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Current methods of testing for human papillomavirus
2001
Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma
1998
Metal carcinogenesis: Mechanistic implications
1992
Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18
1997
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2
2004
A Virus-Like Particle Enzyme-Linked Immunosorbent Assay Detects Serum Antibodies in a Majority of Women Infected With Human Papillomavirus Type 16
1994
The Tumor Suppressor Protein p16 and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System
2004 StandoutNobel
The effects of interferon on the expression of human papillomavirus oncogenes
2000
Differential sensitivity of human papillomavirus type 16+ and type 18+ cervical carcinoma cells to CD95-mediated apoptosis
2001 StandoutNobel
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
1995
Anti-cancer activity of plant-produced HPV16 E7 vaccine
2007
Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
2002
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
E‐cadherin‐dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus‐associated (pre)neoplastic lesions
2005
Effects of β-Carotene and Other Factors on Outcome of Cervical Dysplasia and Human Papillomavirus Infection
1997
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
Human Papillomaviruses and cervical Cancer
1997
Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate radiation
1997
Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study
2008
Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine
2001
Expression of Human papillomavirus 16 E7ggg oncoprotein on N- and C-terminus of Potato virus X coat protein in bacterial and plant cells
2011
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease?
1999
Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF10 PCR and HPV genotyping
2001
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Human papillomavirus-related serological markers of invasive cervical carcinoma in Brazil.
1994
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope
1997
Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants
2003
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection
2009
Development and Clinical Evaluation of a Highly Sensitive PCR-Reverse Hybridization Line Probe Assay for Detection and Identification of Anogenital Human Papillomavirus
1999
Breast cancer and hormone-replacement therapy in the Million Women Study
2003 Standout
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 Standout
Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence.
1996
A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings
1997
Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides
2002
Analysis by Multiplex PCR of the Physical Status of Human Papillomavirus Type 16 DNA in Cervical Cancers
1999
Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2
2005
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method
1998
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
1998
Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
2001
Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments
1995
Human Papillomavirus (HPV) DNA Copy Number Is Dependent on Grade of Cervical Disease and HPV Type
1999
Characterization of a Major Neutralizing Epitope on Human Papillomavirus Type 16 L1
1999
Causes of Cervical Cancer in the Philippines: a Case-Control Study
1998
Human papillomavirus (HPV) in head and neck cancer
1997
Human Papillomavirus and Cervical Cancer
2003 Standout
Association of cervical cancer with the presence of CD4+regulatory T cells specific for human papillomavirus antigens
2007
Risks of Premature Death and Cancer Predicted by Body Weight in Early Adult Life
1991
GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes
2002
Regulate to reduce chemical mixture risk
2018 StandoutScience
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths
2007 Standout
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
The spatial association between community air pollution and mortality: a new method of analyzing correlated geographic cohort data.
2001
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.
1999
Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects.
2002
Nasal Immunization of Mice with Human Papillomavirus Type 16 Virus-Like Particles Elicits Neutralizing Antibodies in Mucosal Secretions
1998
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries
2005
Native State Kinetic Stabilization as a Strategy To Ameliorate Protein Misfolding Diseases: A Focus on the Transthyretin Amyloidoses
2005
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Global cancer statistics, 2012
2015 Standout
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective
1997
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses
1997
Works of J Peto being referenced
Floating absolute risk: An alternative to relative risk in survival and case‐control analysis avoiding an arbitrary reference group
1991
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
1995 Standout
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk
1993
A mortality study among workers in an English asbestos factory.
1977
Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments.
1980
Cancer treatment trials--past failures, current progress and future prospects.
1989
Models for Respiratory Cancer in Nickel Refinery Workers
1986